SECOND AUTOLOGOUS STEM CELL TRANSPLANTATION FOR RELAPSED LYMPHOMA AFTER A PRIOR AUTOLOGOUS TRANSPLANT

We determined treatment-related mortality (TRM), progression free survival (PFS), and overall survival (OS) after a second autologous HCT (HCT2) for patients with lymphoma relapse after a prior HCT (HCT1). Outcomes for patients with either Hodgkin lymphoma (HL, n=21) or non-Hodgkin lymphoma (NHL, n=...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Smith, Sonali M., van Besien, Koen, Carreras, Jeanette, Bashey, Asad, Cairo, Mitchell S., Freytes, Cesar O., Gale, Robert Peter, Hale, Gregory A., Hayes-Lattin, Brandon, Holmberg, Leona A., Keating, Armand, Maziarz, Richard T., McCarthy, Philip L., Navarro, Willis H., Pavlovsky, Santiago, Schouten, Harry C., Seftel, Matthew, Wiernik, Peter H., Vose, Julie M., Lazarus, Hillard M., Hari, Parameswaran
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3353768/
https://ncbi.nlm.nih.gov/pubmed/18640574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2008.05.021
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars